Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LQDA | LIQUIDIA CORP | $57.59 | $17.55 | 228.18% | 239.96x | 21.30x | 17.60x | 47.17x | 1.21x | $41.15M | 0.81% | $108.58M | 1.23 | $5.08B | 94.83 | ||
| SLNO | SOLENO THERAPEUTICS INC | $52.95 | $60.57 | -12.57% | 28.62x | 13.15x | 9.68x | 5.57x | 0.36x | $105.42M | 3.82% | $495.80M | 9.52 | $2.68B | 24.92 | ||
| CORT | CORCEPT THERAPEUTICS INC | $57.08 | $16.15 | 253.40% | 124.09x | 105.20x | 7.75x | 9.60x | 1.42x | $119.79M | 2.01% | $637.99M | 6.11 | $6.03B | -878.03 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $291.48 | $98.34 | 196.40% | 66.85x | 41.11x | 9.04x | 36.19x | 1.33x | $641.34M | 1.66% | $1.08B | 8.09 | $40.18B | 43.46 | ||
| ADMA | ADMA BIOLOGICS INC | $8.50 | $11.73 | -27.55% | 12.32x | 8.56x | 3.94x | 5.05x | 0.36x | $107.90M | 5.38% | $390.33M | 1.65 | $2.03B | 9.16 | ||
| ASND | ASCENDIS PHARMA A | $243.58 | $103.50 | 135.33% | 25.82x | 57.10x | 14.85x | 26.35x | 1.57x | $52.94M | 0.35% | $574.09M | 9.24 | $15.51B | 166.32 | ||
| KRYS | KRYSTAL BIOTECH INC | $312.58 | $102.28 | 205.61% | 40.33x | 39.76x | 21.94x | 7.22x | 1.76x | $237.38M | 2.59% | $1.28B | 43.59 | $8.72B | 40.77 | ||
| OMER | OMEROS CORP | $14.38 | $17.90 | -19.65% | 11.06x | -23.64x | 104.20x | -16.43x | 0.45x | -$94.78M | -9.17% | -$63.33M | -0.88 | $1.35B | 14.92 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $11.12 | $16.33 | -31.89% | 5.42x | 22.43x | 5.31x | 3.19x | 0.71x | $56.42M | 8.69% | $205.80M | 3.52 | $562.91M | 3.89 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $3.76 | $3.02 | 24.43% | 15.67x | 13.78x | 2.30x | 3.64x | 0.74x | $4.11M | 1.36% | $82.33M | 1.03 | $235.49M | 11.09 | ||
| XERS | XERIS BIOPHARMA HOLDINGS INC | $6.43 | $2.86 | 125.16% | 91.86x | 53.81x | 3.48x | 85.32x | 0.89x | $47.52M | 4.34% | $13.01M | 0.08 | $1.26B | 23.52 | ||
| VCEL | VERICEL CORP | $32.84 | $8.75 | 275.31% | 76.37x | 74.01x | 5.71x | 4.71x | 1.74x | $47.49M | 2.85% | $356.23M | 7.02 | $1.66B | 41.13 | ||
| HALO | HALOZYME THERAPEUTICS INC | $70.03 | $71.52 | -2.09% | 23.66x | 8.49x | 5.48x | 37.82x | 0.43x | $667.65M | 8.07% | $219.64M | 1.86 | $10.14B | 16.25 | ||
| RPRX | ROYALTY PHARMA PLC | $53.25 | $42.11 | 26.47% | 27.88x | 10.06x | 9.53x | 3.09x | 0.57x | $2.34B | 10.06% | $9.94B | 22.75 | $39.03B | 33.55 | ||
| ABEO | ABEONA THERAPEUTICS INC | $5.71 | $6.97 | -18.08% | 4.57x | -6.92x | 22.22x | 2.25x | 7.05x | -$85.24M | -26.36% | $144.94M | 2.56 | $287.24M | 3.91 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $59.12 | $16.15 | 265.96% | 60.33x | 53.59x | 6.00x | 7.51x | 1.85x | $164.23M | 3.63% | $605.69M | 7.92 | $4.37B | 39.18 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $232.33 | $49.11 | 373.08% | 494.32x | 9.54x | 3.24x | 3.22x | 1.70x | $1.30B | 9.02% | $4.53B | 73.22 | $18.13B | 26.87 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $53.55 | $41.66 | 28.53% | 38.25x | 11.85x | 3.18x | 1.67x | 0.54x | $767.06M | 7.44% | $6.21B | 32.27 | $8.71B | 18.05 | ||
| TECH | BIO-TECHNE CORP | $44.89 | $16.59 | 170.66% | 63.23x | 22.20x | 5.80x | 3.37x | 1.20x | $269.60M | 3.84% | $2.09B | 13.34 | $7.11B | 27.77 | ||
| SPRO | SPERO THERAPEUTICS INC | $2.44 | $5.83 | -58.14% | 9.04x | 3.57x | 2.28x | 2.67x | 0.19x | $7.24M | 5.16% | $52.93M | 0.92 | $87.62M | 5.65 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $30.83 | $35.59 | -13.37% | 12.19x | 8.64x | 1.98x | 1.96x | 0.48x | $341.79M | 19.17% | $910.35M | 15.75 | $1.35B | 5.72 | ||
| UTHR | UNITED THERAPEUTICS CORP | $579.54 | $264.79 | 118.87% | 19.79x | 19.65x | 7.95x | 4.17x | 1.83x | $1.02B | 4.03% | $5.90B | 135.66 | $23.32B | 13.61 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $221.21 | $82.13 | 169.33% | 28.00x | 23.98x | 16.02x | 4.45x | 1.90x | $122.22M | 2.78% | $997.32M | 50.16 | $4.77B | 21.15 | ||
| EXEL | EXELIXIS INC | $51.29 | $31.32 | 63.78% | 16.44x | 16.34x | 5.58x | 6.66x | 1.20x | $917.69M | 6.93% | $1.94B | 7.49 | $12.84B | 12.15 | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $31.16 | $14.51 | 114.80% | 17.22x | 15.09x | 6.38x | 3.77x | 2.21x | $208.13M | 5.46% | $1.01B | 8.28 | $3.06B | 9.14 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $719.88 | $436.50 | 64.92% | 16.91x | 15.28x | 5.02x | 2.40x | 1.18x | $4.11B | 5.49% | $31.42B | 302.15 | $75.22B | 13.09 | ||
| MDXG | MIMEDX GROUP INC | $3.52 | $1.79 | 96.51% | 16.76x | -258.82x | 1.34x | 2.16x | 1.80x | $69.36M | 13.27% | $242.94M | 1.64 | $382.11M | 7.01 | ||
| PBYI | PUMA BIOTECHNOLOGY INC | $7.17 | $4.36 | 64.40% | 14.34x | 17.57x | 1.60x | 2.84x | 1.45x | $53.60M | 14.70% | $128.42M | 2.53 | $342.62M | 7.62 | ||
| PLX | PROTALIX BIOTHERAPEUTICS INC | $1.93 | $1.77 | 9.05% | 10.16x | 8.89x | 2.02x | 2.31x | 0.88x | $13.00M | 8.45% | $67.23M | 0.84 | $122.27M | 5.48 | ||
| SRPT | SAREPTA THERAPEUTICS INC | $18.84 | $6.82 | 176.22% | 31.40x | 5.91x | 0.91x | 1.32x | 1.78x | $109.24M | 5.52% | $1.51B | 14.34 | $2.56B | 30.96 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $453.06 | $176.62 | 156.51% | 26.63x | 23.27x | 9.42x | 5.94x | 1.81x | $3.71B | 3.22% | $19.36B | 76.20 | $111.48B | 20.67 | ||
| VCYT | VERACYTE INC | $38.25 | $9.02 | 323.83% | 34.46x | 41.82x | 5.62x | 2.27x | 4.24x | $155.34M | 5.11% | $1.34B | 16.90 | $2.83B | 24.57 | ||
| INCY | INCYTE CORP | $98.82 | $67.67 | 46.04% | 13.56x | 12.61x | 3.67x | 3.51x | 1.18x | $1.45B | 7.36% | $5.62B | 28.21 | $16.31B | 8.72 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.